Factors involved in upregulation of inducible nitric oxide synthase in rat small intestine following administration of nonsteroidal anti-inflammatory drugs

Digestive Diseases and Sciences

Volumn 51, Issue 7, 2006, Pages 1250-1259

  Takeuchi, Koji ^a   Yokota, Aya ^a   Tanaka, Akiko ^a   Takahira, Yuka ^a  

^a KYOTO PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

COX 1 inhibition; Enterobacteria; iNOS expression; Intestinal damage; Intestinal motility; NSAID

Indexed keywords

5 (4 CHLOROPHENYL) 1 (4 METHOXYPHENYL) 3 TRIFLUOROMETHYL 1H PYRAZOLE; AMPICILLIN; ATROPINE; CYCLOOXYGENASE 1 INHIBITOR; CYCLOOXYGENASE 2 INHIBITOR; DICLOFENAC; FLURBIPROFEN; INDOMETACIN; NAPROXEN; NITRIC OXIDE SYNTHASE; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN E2; ROFECOXIB;

ANIMAL EXPERIMENT; ARTICLE; BACTERIAL GROWTH; FOOD DEPRIVATION; GASTROINTESTINAL HEMORRHAGE; INTESTINAL DYSMOTILITY; INTESTINE MUCOSA; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SMALL INTESTINE; TERATOGENICITY; UPREGULATION;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CYCLOOXYGENASE INHIBITORS; DICLOFENAC; DINOPROSTONE; DISEASE MODELS, ANIMAL; ENTEROBACTERIACEAE; FLURBIPROFEN; GASTROINTESTINAL MOTILITY; INDOMETHACIN; INTESTINAL DISEASES; INTESTINAL MUCOSA; INTESTINE, SMALL; LACTONES; MALE; NAPROXEN; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; PYRAZOLES; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; SULFONES; TIME FACTORS; UP-REGULATION;

EID: 33748412754     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-006-8045-4     Document Type: Article

References (30)

1. Robert A, Asano T: Resistance of germ-free rats to indomethacin-induced intestinal inflammation. Prostaglandins 14:333-341, 1987
2. Fang WF, Broughton A, Jacobson ED: Indomethacin induced intestinal inflammation. Am J Dig Dis 22:749-760, 1977
3. Bjarnason I, Zanelli G, Smith T, et al.: Nonsteroidal anti-inflammatory drug-induced intestinal inflammation in humans. Gastroenterology 93:480-489, 1987
4. Weissenborn U, Maedge S, Buettner D, Sewing KF: Indomethacin-increased gastrointestinal lesions in relation to tissue concentration, food intake and bacterial invasion in the rat. Pharmacology 30:32-39, 1985
5. Whittle BJR: Temporal relationship between cyclooxygenase inhibition, as measured by prostacyclin biosynthesis, and the gastrointestinal damage induced by indomethacin in the rat. Gastroenterology 80:94-98, 1981
6. Whittle BJR, Laszlo F, Evans AM, Moncada S: Inducible nitric oxide synthase and microvascular injury in the rat jejunum provoked by indomethacin. Br J Pharmacol 116:2286-2290, 1995
7. Wallace JL, McKnight W, Reuter BK, Vergnolle N: NSAID-induced gastric damage in rats: requirement for inhibition of both cyclo-oxygenase 1 and 2. Gastroenterology 119:706-714, 2000
8. Gretzer B, Maricic N, Respondek M, Schuligoi R, Peskar BM: Effects of specific inhibition of cyclo-oxygenase-1 and cyclo-oxygenase-2 in the rat stomach with normal mucosa and after acid challenge. Br J Pharmacol 132:1565-1573, 2001
9. Takeuchi K, Tanaka A, Suzuki K, Mizoguchi H, Araki H: Gastrointestinal sparing anti-inflammatory drugs: effects on ulcerogenic and healing responses. Current Pharmaceutical Design 7:49-71, 2001
10. Tanaka A, Araki H, Hase S, Komoike Y, Takeuchi K: Inhibition of both COX-1 and COX-2 is required for development of gastric damage in response to nonsteroidal antiinflammatory drugs. J Physiol Paris 95:21-27, 2001
11. Tanaka A, Hase S, Miyazawa T, Takeuchi K: Up-regulation of COX-2 by inhibition of COX-1: A key to NSAID-Induced intestinal damage. J Pharmacol Exp Ther 300:754-761, 2002
12. Boughton-Smith N, Evans SM, Laszlo F, Whittle BJR, Moncada S: The induction of nitric oxide synthase and intestinal vascular permeability by endotoxin in the rat. Br J Pharmacol 110:1189-1195, 1993
13. Konaka A, Nishijima M, Tanaka A, Kunikata T, Kato S, Takeuchi K: Nitric oxide, superoxide radicals and mast cells in Pathogenesis of indomethacin-induced small intestinal lesions in rats. J Physiol Pharmacol 50:25-38, 1999
14. Tanaka A, Kunikata T, Konaka A, Kato S, Takeuchi K: Dual action of nitric oxide in pathogenesis of indomethacin-induced small intestinal ulceration in rats. J Physiol Pharmacol 50:405-417, 1999
15. Takeuchi K, Miyazawa T, Tanaka A, Kato S, Kunikata T: Pathogenic importance of intestinal hypermotility in NSAID-induced small intestinal damage in rats. Digestion 66:30-41, 2002
16. Smith CJ, Zhang Y, Koboldt CM, et al.: Pharmacological analysis of cyclooxygenase-1 in inflammation. Proc Natl Acad Sci USA 95:13313-13318, 1998
17. Chan CC, Boyce S, Bridear C, et al.: Pharmacology of a selective cyclooxygenase-2 inhibitor L-745,337: a novel non-steroidal anti-inflammatory agent with an ulcerogenic sparing effect in rat and non-human primate stomach. J Pharmacol Exp Ther 274:1531-1537, 1995
18. Futaki N, Takahashi S, Yokoyama M, Arai I, Higuchi S, Otomo S: NS-398, a new antiinflammatory agent, selectively inhibits prostaglandin G/H synthase/cyclo-oxygenase (COX-2) activity in vitro. Prostaglandins 47:55-59, 1994
19. Tanaka A, Hase S, Miyazawa T, Ohno R, Takeuchi K: Role of COX-1 and COX-2 inhibition in NSAID-induced intestinal damage in rats: relation to various pathogenic events. J Pharmacol Exp Ther 303:1248-1254, 2002
20. Feng L, Sun W, Xia Y, et al.: Cloning two isoforms of rat cyclo-oxygenase: Differential regulation of their expression. Arch Biochem Biophys 307:361-368, 1993
21. 2 inhibits indomethacin-induced small intestinal lesions through EP3 and EP4 receptors. Dig Dis Sci 47:894-904, 2002
22. Brown JF, Tepperman BL, Hanson PJ, Whittle BJR, Moncada S: Differential distribution of nitric oxide synthase between cell fractions isolated from the rat gastric mucosa. Biochem Biophys Res Comm 184:680-685, 1992
23. Green LC, Tannebaum SR, Goldman P: Nitrite synthesis in the germ free and conventional rat. Science 212:56-58, 1981
24. Reuter BK, Davies NM, Wallace JL: Nonsteroidal anti-inflammatory drug enteropathy in rats: role of permeability, bacteria, and enterohepatic circulation. Gastroenterology 112:109-117, 1997
25. Tanaka A, Matsumoto M, Hayashi Y, Takeuchi K: Functional mechanism underlying cyclooxygenase-2 expression in rat small intestine following administration of indomethacin: relation to intestinal hypermotility. J Gastroenterol Hepatol 20:38-45, 2005
26. Bertrand V, Guimbaud R, Tulliez M, et al.: Increase in tumor necrosis factor-α production linked to the toxicity of indomethacin for the rat small intestine. Br J Pharmacol 124:1385-1394, 1998
27. Konaka A, Nishijima M, Tanaka A, Kato S, Takeuchi K: Roles of enterobacteria, nitric oxide and neutrophil in pathogenesis of indomethacin-induced small intestinal lesions in rats. Pharmacol Res 40:517-524, 1999
28. Evans SM, Whittle BJ: Interactive roles of superoxide and inducible nitric oxide synthase in rat intestinal injury provoked by non-steroidal anti-inflammatory drugs. Eur J Pharmacol 429:287-96, 2003
29. Mizoguchi H, Miyazawa T, Ogawa Y, Tanaka A, Kato S, Takeuchi K: Protective effect of rebamipide on indomethacin-induced intestinal damage in rats. J Gastroent Hepatol 16:1112-1119, 2001
30. Lamarque D, Nhieu JT, Breban M, et al.: Lymphocytic infiltration and expression of inducible nitric oxide synthase in human duodenal and colonic mucosa is a characteristic feature of ankylosing spondylitis. J Rheumatol 30:2428-2436, 2003